The Pectra protocol upgrade introduces several core technical improvements to XBIT. By adopting a Multi-Dimensional Consensus ...

ZURICH, SWITZERLAND, May 29, 2025 -- VERAXA Biotech AG ("VERAXA”), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp.